Register for our free email digests:
Sarepta Therapeutics Inc.
www.sarepta.com
Latest From Sarepta Therapeutics Inc.
The SMA Market: Assessing The Unknowns
The introductions of Spinraza and Zolgensma in SMA offer new insights into how to address neurodegenerative diseases. But more real world evidence is needed.
US FDA's New Neurology Leadership Likely To Face Two Big Reviews In 2020
Eric Bastings will lead Division of Neurology I, which is expected to handle Biogen’s Alzheimer’s drug aducanumab and Sarepta’s refiling of golodirsen for DMD next year.
Deal Watch: Molecular Templates Aligns With Vertex On Optimizing Stem Cell Candidates
Alliance with Molecular Templates may help advance efforts under Vertex’s existing collaboration with CRISPR Therapeutics. Dragonfly’s latest partner for its TriNKET platform is AbbVie.
Deal Watch: Allergan Keeps After Hair Loss With Exicure Deal
Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.
Company Information
- Industry
-
Biotechnology
- Antisense, Oligonucleotides
- Gene Therapy, Cell Therapy
- Large Molecule
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Infectious & Viral Diseases
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Alias(es)
- AVI BioPharma Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Sarepta Therapeutics Inc.
- Senior Management
-
Douglas Ingram, Pres. & CEO
Sandesh Mahatme, EVP, CFO & CBO
Bo Cumbo, EVP, Chief Commercial Officer
Gilmore O'Neill, SVP, R&D & CMO
Gary Charbonneau, SVP, Reg. Affairs - Contact Info
-
Sarepta Therapeutics Inc.
Phone: (617) 274-4000
215 First St.
Cambridge, MA 02142
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice